These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4815338)

  • 21. Aspects of influx and efflux of homovanillic acid of rat cerebrospinal fluid.
    Aizenstein ML; Korf J
    Brain Res; 1978 Jun; 149(1):129-40. PubMed ID: 656951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
    Cunha L; Gonçalves AF; Oliveira C; Dinis M; Amaral R
    Can J Neurol Sci; 1983 Feb; 10(1):43-6. PubMed ID: 6839227
    [No Abstract]   [Full Text] [Related]  

  • 23. Origins of catecholamine metabolites in monkey cerebrospinal fluid.
    Gordon E; Perlow M; Oliver J; Ebert M; Kopin I
    J Neurochem; 1975 Sep; 25(3):347-9. PubMed ID: 808591
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 25. Homovanillic acid and 3-methoxy-4-hydroxyphenylethyleneglycol production by the monkey spinal cord.
    Kessler JA; Gordon EK; Reid JL; Kopin IJ
    J Neurochem; 1976 Jun; 26(6):1057-61. PubMed ID: 819631
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlations between a fluorimetric and mass fragmentographic method for the determination of 3-methoxy-4-hydroxyphenylacetic acid and two mass fragmentographic methods for the determination of 3-methoxy-4- hydroxyphenylethylene glycol in cerebrospinal fluid.
    Muskiet FA; Jeuring HJ; Korf J; Sedvall G; Westerink BH; Teelken AW; Wolthers BG
    J Neurochem; 1979 Jan; 32(1):191-4. PubMed ID: 759571
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

  • 29. Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.
    Guldberg HC; Ashcroft GW; Crawford TB
    Life Sci; 1966 Sep; 5(17):1571-5. PubMed ID: 5970680
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cerebrospinal fluid homovanillic acid in paralysis agitans and spinocerebellar degeneration (author's transl)].
    Mizuno Y; Ariga T
    Rinsho Shinkeigaku; 1979 Jun; 19(6):367-71. PubMed ID: 477137
    [No Abstract]   [Full Text] [Related]  

  • 31. Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
    Extein I; Roth RH; Bowers MB
    Biol Psychiatry; 1974 Oct; 9(2):161-70. PubMed ID: 4429746
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid and brain of different rabbit breeds after treatment with probenecid.
    Andersson H; Roos BE
    J Pharm Pharmacol; 1972 Feb; 24(2):165-6. PubMed ID: 4401976
    [No Abstract]   [Full Text] [Related]  

  • 34. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
    Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM
    Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homovanillic acid in cerebrospinal fluid of alcoholics.
    Roos BE; Silfverskiöld BP
    N Engl J Med; 1973 Jun; 288(25):1358-9. PubMed ID: 4706282
    [No Abstract]   [Full Text] [Related]  

  • 36. CSF homovanillic acid: effects of probenecid and alpha-methyltyrosine.
    Bowers MB
    Life Sci I; 1970 Jun; 9(12):691-4. PubMed ID: 5473333
    [No Abstract]   [Full Text] [Related]  

  • 37. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
    Faull KF; Guilleminault C; Berger PA; Barchas JD
    Ann Neurol; 1983 Mar; 13(3):258-63. PubMed ID: 6189447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.
    Bowers MB; Heninger GR
    Psychiatry Res; 1981 Jun; 4(3):285-90. PubMed ID: 6115436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.